Panacea Biotec Limited — Board Meeting, 13-11-2024: Outcome of Board Meeting

The Board of Directors of Panacea Biotec Limited has announced a board meeting to discuss the financial results for the quarter and half-year. Key agenda items include the unaudited standalone and consolidated financial performance for the period ending September 30, 2024, which will provide insights into the company's operational status. Additionally, the board will review a proposal for raising USD 20 million through external commercial borrowings aimed at expanding vaccine manufacturing capabilities and refinancing existing loans. This meeting reflects strategic steps towards enhancing the company’s growth trajectory.